Result of AGM
CRISM Therapeutics Corporation announced that all resolutions were passed at its Annual General Meeting, with overwhelming support for each resolution, including votes for ranging from 22,570,769 to 22,590,952, representing 99.99% for each. This strong shareholder backing indicates continued confidence in the company's management and strategic direction as it progresses with its clinical-stage drug delivery technology focused on localized chemotherapy.
Select text to share a quote on X · sign in to keep highlights & notes in your CRTX notes
CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, is pleased to confirm that at the Company's Annual General Meeting held earlier today, all resolutions were duly passed.
Full details of the resolutions are set out in the Notice of Annual General Meeting dated 2 October 2026, which is available on the Company's website at: https://www.crismtherapeutics.com/investors/documents-circulars/
The votes cast were as follows:
| Resolution | Votes for | Votes for % | Votes against | Votes against % | Abstentions |
|---|---|---|---|---|---|
| 1 | 22,590,952 | 99.99% | 280 | 0.01% | 3,572 |
| 2 | 22,590,014 | 99.99% | 1,224 | 0.01% | 3,566 |
| 3 | 22,590,221 | 99.99% | 955 | 0.01% | 3,628 |
| 4 | 22,590,227 | 99.99% | 949 | 0.01% | 3,628 |
| 5 | 22,590,215 | 99.99% | 949 | 0.01% | 3,640 |
| 6 | 22,590,227 | 99.99% | 949 | 0.01% | 3,628 |
| 7 | 22,590,909 | 99.99% | 329 | 0.01% | 3,566 |
| 8 | 22,583,989 | 99.99% | 2,139 | 0.01% | 8,676 |
| 9 | 22,570,769 | 99.99% | 2,791 | 0.01% | 21,244 |
The Company's LEI is 213800XFW6MKVCHHPW88.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.